Medicaid Coverage Of Cessation Treatments And Barriers To Treatments

2008-2022. American Lung Association. Cessation Coverage. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment; types of counseling recommended by the Public Health Service (PHS) and barriers to accessing cessation treatment. Note: Section 2502 of the Patient Protection and Affordable Care Act requires all state Medicaid programs to cover all FDA-approved tobacco cessation medications as of January 1, 2014. However, states are currently in the process of modifying their coverage to come into compliance with this requirement. Data in the STATE System on Medicaid coverage of tobacco cessation medications reflect evidence of coverage that is found in documentable sources, and may not yet reflect medications covered under this requirement.

Data and Resources

Field Value
accessLevel public
bureauCode {009:20}
catalog_@context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
catalog_@id https://data.cdc.gov/data.json
catalog_conformsTo https://project-open-data.cio.gov/v1.1/schema
catalog_describedBy https://project-open-data.cio.gov/v1.1/schema/catalog.json
describedBy https://chronicdata.cdc.gov/Cessation-Coverage-/Medicaid-Coverage-Of-Cessation-Treatments-And-Barr/ntaa-dtex
identifier https://data.cdc.gov/api/views/ntaa-dtex
issued 2019-04-12
landingPage https://data.cdc.gov/d/ntaa-dtex
modified 2022-07-25
programCode {009:020}
publisher Centers for Disease Control and Prevention
references {https://chronicdata.cdc.gov/d/x7ys-5vpn}
resource-type Dataset
source_datajson_identifier true
source_hash be7be97af3758c7fa1296bba9da51fcdf053455c
source_schema_version 1.1
theme {"Cessation Coverage "}
Groups
  • AmeriGEOSS
  • National Provider
  • North America
Tags
  • american-lung-association
  • amerigeo
  • amerigeoss
  • cessation-coverage
  • ckan
  • comprehensive-medicaid-coverage
  • geo
  • geoss
  • medicaid-coverage-of-cessation-treatment
  • national
  • north-america
  • office-on-smoking-and-health
  • osh
  • united-states
isopen False
license_id notspecified
license_title License not specified
maintainer CDC INFO
maintainer_email nccdoshinquiries@cdc.gov
metadata_created 2025-11-19T15:01:51.847159
metadata_modified 2025-11-19T15:01:51.847165
notes 2008-2022. American Lung Association. Cessation Coverage. Medicaid data compiled by the Centers for Disease Control and Prevention’s Office on Smoking and Health were obtained from the State Tobacco Cessation Coverage Database, developed and administered by the American Lung Association. Data from 2008-2012 are reported on an annual basis; beginning in 2013 data are reported on a quarterly basis. Data include state-level information on Medicaid coverage of approved medications by the Food and Drug Administration (FDA) for tobacco cessation treatment; types of counseling recommended by the Public Health Service (PHS) and barriers to accessing cessation treatment. Note: Section 2502 of the Patient Protection and Affordable Care Act requires all state Medicaid programs to cover all FDA-approved tobacco cessation medications as of January 1, 2014. However, states are currently in the process of modifying their coverage to come into compliance with this requirement. Data in the STATE System on Medicaid coverage of tobacco cessation medications reflect evidence of coverage that is found in documentable sources, and may not yet reflect medications covered under this requirement.
num_resources 4
num_tags 14
title Medicaid Coverage Of Cessation Treatments And Barriers To Treatments